|
|
|
STAGE |
|
|
|
IA |
IB |
IIA |
IIB |
IIIA |
IIIB |
IV |
NSCLC▪ |
THERAPY |
Surgery |
n |
31 |
38 |
0 |
3 |
4 |
4 |
2 |
|
|
|
% |
67.4% |
39.6% |
0.0% |
8.8% |
5.8% |
1.6% |
0.9% |
|
|
CT▪ |
n |
0 |
8 |
0 |
4 |
17 |
81 |
68 |
|
|
|
% |
0.0% |
8.3% |
0.0% |
11.8% |
24.6% |
32.7% |
29.1% |
|
|
RT▪ |
n |
2 |
11 |
0 |
2 |
6 |
17 |
30 |
|
|
|
% |
4.3% |
11.5% |
0.0% |
5.9% |
8.7% |
6.9% |
12.8% |
|
|
Palliative care |
n |
3 |
12 |
1 |
16 |
17 |
85 |
80 |
|
|
|
% |
6.5% |
12.5% |
50.0% |
47.1% |
24.6% |
34.3% |
34.2% |
|
|
Surgery+CT |
n |
4 |
7 |
0 |
4 |
3 |
4 |
3 |
|
|
|
% |
8.7% |
7.3% |
0.0% |
11.8% |
4.3% |
1.6% |
1.3% |
|
|
CT+RT |
n |
0 |
4 |
0 |
2 |
15 |
53 |
51 |
|
|
|
% |
0.0% |
4.2% |
0.0% |
5.9% |
21.7% |
21.4% |
21.8% |
|
|
Surgery+CT+RT |
n |
2 |
4 |
0 |
2 |
5 |
3 |
0 |
|
|
|
% |
4.3% |
4.2% |
0.0% |
5.9% |
7.2% |
1.2% |
0.0% |
|
|
Surgery+RT |
n |
4 |
12 |
1 |
1 |
2 |
1 |
0 |
|
|
|
% |
8.7% |
12.5% |
50.0% |
2.9% |
2.9% |
0.4% |
0.0% |
SCLC▪ |
THERAPY |
Surgery |
n |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
|
|
|
% |
0.0% |
14.3% |
0.0% |
14.3% |
0.0% |
1.1% |
0.0% |
|
|
CT▪ |
n |
0 |
1 |
0 |
1 |
10 |
31 |
52 |
|
|
|
% |
0.0% |
14.3% |
0.0% |
14.3% |
25.6% |
33.3% |
44.4% |
|
|
RT▪ |
n |
0 |
0 |
0 |
0 |
1 |
1 |
9 |
|
|
|
% |
0.0% |
0.0% |
0.0% |
0.0% |
2.6% |
1.1% |
7.7% |
|
|
Palliative care |
n |
2 |
1 |
1 |
2 |
1 |
16 |
31 |
|
|
|
% |
66.7% |
14.3% |
100.0% |
28.6% |
2.6% |
17.2% |
26.5% |
|
|
Surgery+CT |
n |
0 |
2 |
0 |
0 |
1 |
0 |
0 |
|
|
|
% |
0.0% |
28.6% |
0.0% |
0.0% |
2.6% |
0.0% |
0.0% |
|
|
CT+RT |
n |
1 |
2 |
0 |
2 |
25 |
44 |
25 |
|
|
|
% |
33.3% |
28.6% |
0.0% |
28.6% |
64.1% |
47.3% |
21.4% |
|
|
Surgery+CT+RT |
n |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
|
|
|
% |
0.0% |
0.0% |
0.0% |
14.3% |
2.6% |
0.0% |
0.0% |
|
▪ NSCLC: LC non small cell
▪ SCLC: LC small cell
▪ CT: chemotherapy.
▪ RT: radiation therapy |
| Table 2: Percentage of patients receiving different therapies. |
